Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI)

Current Hypertension Reviews

Volumn 9, Issue 1, 2013, Pages 66-75

  Shirai, Kohji ^a,b   Utino, Junji ^b   Saiki, Atsuhito ^a   Endo, Kei ^a   Ohira, Masahiro ^a   Nagayama, Daiji ^a   Tatsuno, Ichiro ^a   Shimizu, Kazuhiro ^a   Takahashi, Mao ^a   Takahara, Akira ^c  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Mihama Hospital   (Japan)

^c TOHO UNIVERSITY   (Japan)

Author keywords

Angiotensin II receptor blockers; Arterial stiffness; Calcium channel blocker; Cardio ankle vascular index; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BERAPROST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SUNITINIB; TELMISARTAN; THIAZIDE DIURETIC AGENT;

AORTA; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; BLOOD PRESSURE REGULATION; BRAIN INFARCTION; CARDIO ANKLE VASCULAR INDEX; CARDIOMETABOLIC RISK; CARDIOVASCULAR PARAMETERS; CAROTID ARTERIOSCLEROSIS; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMORAL ARTERY; HUMAN; HYPERTENSION; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; METABOLIC SYNDROME X; OBESITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULSE WAVE; REVIEW; RISK REDUCTION; SLEEP DISORDERED BREATHING; SMOKING CESSATION; SMOOTH MUSCLE CONTRACTION; SYSTOLIC BLOOD PRESSURE; TIBIAL ARTERY; VASOMOTOR REFLEX; WEIGHT CONTROL;

ANGIOTENSIN II RECEPTOR BLOCKERS; ARTERIAL STIFFNESS; CALCIUM CHANNEL BLOCKER; CARDIO-ANKLE VASCULAR INDEX; HYPERTENSION.;

ANKLE; ANKLE JOINT; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; FEMORAL ARTERY; HUMANS; HYPERTENSION; PULSE WAVE ANALYSIS; TIBIAL ARTERIES; VASCULAR STIFFNESS;

EID: 84875304529     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/1573402111309010010     Document Type: Review

References (68)

1. Asmar R. Pulse wave velocity principles and measurement 25-55. In: Arterial stiffness and pulse wave velocity, edited by Asmar R, O'Rourke MF, Safar M. Elsevier, Amsterdam, 1999.
2. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003; 23: 554-566.
3. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113: 657-663.
4. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15: 426-444.
5. Koizumi M, Shimizu H, Shimomura K, et al. Relationship between hyperinsulinemia and pulse wave velocity in moderately hyperglycemic patients. Diabetes Res Clin Pract 2003; 62: 17-21.
6. Avest E, Holewijn S, Bredie SJ, van Tits LJ, Stalenhoef AF, de Graaf J. Pulse wave velocity in familial combined hyperlipidemia. Am J Hypertens 2007; 20: 263-269.
7. Tanaka H, Munakata M, Kawano Y, et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 2009; 27: 2022-2027
8. Lemogoum D, Flores G, Van den Abeele W, et al. Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation. J Hypertens 2004; 22: 511-517.
9. Asmar R, Benetos SA, Topuchian J, et al. Assessment of arterial distensability by autmatic pulse wave velosity measurment: Validation and clinical application studies. Hypertension 1995; 26: 485-490
10. Kimoto E, Shoji T, shinohara K, et al. Preferential stiffening of central over peripheral arteries intype 2 diabetes mellitus. Diabetes 2003; 52: 448-452.
11. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
12. Kim HJ, Nam JS, Park JS, et al. Usefulness of brachial-ankle pulse wave velocity as a predictive marker of multiple coronary artery occlusive disease in Korean type 2 diabetes patients. Diabetes Res Clin Pr 2009; 85: 30-34.
13. Seo WW, Chang HJ, Cho I, et al. The value of brachial-ankle pulse wave velocity as a predictor of coronary artery disease in high-risk patietns. Korean Circ J 2010; 40: 224-229.
14. Alvim RD, Santos PC, Dias RG, et al. Association between the C242T polymorphism in the p22phox gene with arterial stiffness in the Brazilian population. Physiol Genomics 2012; 44: 587-592.
15. Rezai MR, Wallace AM, Sattar N, Finn JD, wu FC, Cruickshank JK, Ethnic differences in aortic pulse wave velosity occur in the descending aorta and may be related to vitamin D. Hypertension 2100; 58: 247-253.
16. Nye ER, The effect of blood pressure alteration on the pulse wave velocity. Br Heart J 1964; 266: 261-265.
17. Van Bortel LM, Duprez D, Starmans-Kool MJ, et al. Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 2002; 15: 445-452.
18. Hayashi K, Handa H, Nagasawa S, Okumura A, Moritake K. Stiffness and elastic behavior of human intracranial and extracranial arteries. J Biomech 1980; 13: 175-184.
19. Kawasaki T, Sasayama S, Yagi S. Noninvasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovascular Res 1987; 21: 678-687.
20. Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; Cardio-ankle vascular index (CAVI). J Atheroscler Thromb 2006; 13: 101-107.
21. Takaki A, Ogawa H, Wakeyama T, et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J 2007; 71(11): 1710-1714.
22. Satoh N, Shimatsu A, Kato Y, et al. Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obese and metabolic syndrome. Hypertension Res 2008; 31: 1921-1930
23. Kubozono T, Miyata M, Ueyama K, et al. Clinical significance and reproducibility of new arterial distensability Index. Circ J 2007; 71: 89-94
24. Shirai K, Song M, Suzuki J, et al. Contradictory effects of p1 - and a1- aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI) -the independency of CAVI from blood pressure. J Atheroscler Thromb2011; 18: 49-55
25. Namekata T, Suzuki K, Ishizuka N, Shirai K. Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovas Disord 2011; 11: 51.
26. Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H. -ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J 2008; 72: 598-604.
27. Bramwell JC, Hill AV. Velocity of the pulse wave in man. Proc Roy Soc 1922; B: 298-306.
28. Izuhara M, Shioji K, Kadota Y, et al. Rekationship of cardio-vasular index to carotid and coronary arteriosclerosis. Circ J 2008; 72: 1762-1767.
29. Miyoshi T, Doi M, Hirohata S, et al. Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. J Atheroscler Thromb 2010; 17: 249-258.
30. Horinaka S, Yabe A, Yagi H, et al. Comparison of atherosclerotic indicators between cardio ankle vascular index and brachial ankle pulse wave velocity. Angiology 2009; 60: 468-476.
31. Sairaku A, Eno S, Hondo T, et al. Head-to-head comparison of the cardio-ankle vascular index between patients with acute coronary syndrome and stable angina pectoris. Hypertens Res 2010; 33: 1162-1166
32. Kubozono T, Miyata M, Ueyama K, et al. Association between arterial stiffness and estimated glomerular filtration rate in the Japanese general population. J Atheroscler Thromb 2009; 16: 840-845.
33. Nakamura K, Iiduka T, Takahashi M, et al. Association between cardio-ankle vascular index and serum cystain c levels in patients with cardiovascular risk factor. J Atheroscler Thromb 2009; 16:371379-370.
34. Ueyama K, Miyata M, Kubozono T, et al. Noninvasive indices of arterial stiffness in hemodialysis patients. Hypertens Res 2009; 32:716-720.
35. Ichihara A, Yamashita N, Takemitsu T, et al. Cardio-ankle vascular index and ankle pulse wave velocity as a marker of arterial fibrosis in kidney failure treated by hemodialysis. Am J Kidney Dis 2008; 52: 947-955.
36. Satoh-Asahara N, Suganami T, Majima T, et al. and the Japan Obesity and Metabolic Syndrome Study (JOMS) Group Urinary Cystatin C as a Potential Risk Marker for Cardiovascular Disease and Chronic Kidney Disease in Patients with Obesity and Metabolic Syndrome. Clin J Am Soc Nephrol 2011; 6: 265-273.
37. Suzuki J, Sakakibara R, Tomaru T, et al. Stroke and Cardio-ankle Vascular Stiffness Index. J Stroke Cerebrovasc Dis. (Epub: August 19, 2011).
38. Namekata T, Suzuki K, Ishizuka N, et al. Association of Cardio-Ankle Vascular Index with Cardiovascular Disease Risk Factors and Coronary Heart Disease among Japanese Urban Workers and their Families. J Clinic Experiment Cardiol 2012; S1-003.
39. Ibata J, Sasaki H, Kakimoto T, et al. Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pract 2008; 80: 265-270
40. Nagayama D, Saiki A, Endo K, et al. Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients. Int J Clin Pract 2010; 64: 1796-1801
41. Ohira M, Endo K, Oyama T, et al. Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70. Metabolism 2011; 60: 78-85
42. Soska V, Dobsak P, Dusek L, et al. Cardio-Ankle Vascular Index in Heterozygous Familial Hypercholesterolemia. J Atheroscler Thromb, 2012; 19: 453-461
43. Miyashita Y, Endo K, Saiki A, et al. Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, oncardio-ankle vascular index in type 2 diabetic patients. J Atheroscler Thromb 2009; 16: 539-545.
44. Miyashita Y, Endo K, Saiki A, et al. Effect of ezetimibe monotherapy on lipid metabolism and arterial patients. J Atheroscler Thromb 2010; 17: 1070-6.
45. Satoh N, Shimatsu A, Kotani K, et al. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome. Hypertens Res, 2009;32:1004-1008.
46. Nagayama D, Endo K, Ohira M, et al. Effects of body weight reduction on cardio-ankle vascular index (CAVI). Ob Res Clin Prac (Epub: October 5, 2011).
47. Noike H, Nakamura K, Sugiyama Y, et al. Changes in cardio-ankle vascular index in smoking cessation. J Atheroscler Thromb 2010; 17: 517-525
48. Kumagai T, Kasai T, Kato M, et al. Establishment of the cardio-ankle vascular index in patients with obstructive sleep apnea. Chest 2009; 136: 779-786.
49. Kasai T, Inoue K, Kumagai T, et al. Plasma pentraxin3 and arterial stiffness in men with obstructive sleep apnea. Am J Hypertens 2011; 24: 401-407.
50. Kubota Y, Maebuchim D, Takei M, et al. Cardio-Ankle Vascular Index is a predictor of cardiovascular events. Artery Res 2011; 5: 91-96.
51. Kim B, Takada K, Oka S, Misaki T. Influence of blood pressure on cardio-ankle vascular index (CAVI) examined based on percentage change during general anesthesia. Hypertens Res 2011; 34: 779-783.
52. Takahashi M, Shiba T, Hirano K, Hitsumoto T, Shirai K. Acute Decrease of Cardio-Ankle Vascular Index with the Administration of Beraprost Sodium. J Atheroscler Thromb 2012; 19: 479-484.
53. Endo K, Saiki A, Ohira M, Miyashita Y, Shirai K. Cardio-ankle vascular index may reflect endothelial function. Int J Clin Pract 2011 65:1200-1201.
54. Okura T, Watanabe S, Kurata M, et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res 2007; 30: 335-340.
55. Sakane K, Miyoshi T, Doi T, et al. Assocoation of new arterial stiffness parameter, the cardio-ankle vascular index, with left ventricular diastolic function. J Atheroscler Thromb 2008; 15: 261-268.
56. Kadota K, Takamura N, Aoyagi K, et al. Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis. Circ J 2008; 72: 304-308.
57. Takaki A, Ogawa H, Wakeyama T, et al. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res 2008; 31: 1347-1355.
58. Masugata H, Senda S, Himoto T, et al. Early detection of hypertension in a patient treated with sunitinib by measuring cardio-ankle vascular index. Tohoku J Exp Med 2009; 218: 115-119.
59. Yoshida A, Suhiyama T, Sagawa N. Assessment of the cardioankle vascular index in pregnant women complicated with hypertensive disorders. ISRN Obstet Gynecol 2011; 2011: 919816.
60. Kurata M, Okura T, Watanabe S, et al. Effects of amlodipine and candesartan on arterial stiffness estimated by cardio-ankle vascular index in patients with essential hypertension: A 24-week study. Curr Ther Res 2008; 69: 412-422.
61. Miyashita Y, Saiki A, Endo K, et al. Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension. J Atheroscler Thromb 2009; 16: 621-626.
62. Sasaki H, Saiki A, Endo K, et al. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. J Atheroscler Thromb 2009; 16: 568-75.
63. Kinouchi K, Ichihara A, Sakoda M, Kurauchi-Mito A, Murohashi-Bokuda K, Itoh H. Effects of telmisartan on arterial stiffness assessed by the cardio-ankle vascular index in hypertensive patients. Kidney Blood Press Res 2010; 33: 304-312.
64. Uehara G, Takeda H. Relative effects of telmisartan, candesartan and losartan on alleviateing arterial stiffnes inpatients with hypertension complicated by diabetes mellitus: An evaluation using the cardiovascular index. J Inter Medical Res 2008; 36: 1094-1102.
65. Bukuda, Ichihara A, Sakoda M, Mito A, Kinouchi K, Itoh H. Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome. Vasc Health Risk Manag 2010; 6: 571-578.
66. Ogihara T, Fujimoto A, Nakao K, Saruta T. ARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trial. Ex Revf Cardiovasc Ther 2008; 6(9): 1195-1201.
67. Ishimitsu T, Numabe A, Masuda T, et al. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension. Hypertens Res 2009; 32: 962-968.
68. Kinouchi K, Ichihara A, Sakoda M, Kurauchi-Mito A, Itoh H. Safety and benefits of a tablet combining losartan and hydro-chlorothiazide in Japanese diabetic patients with hypertension. Hypertens Res 2009; 32: 1143-1147.